APCR

AcronymDefinition
APCRActivated Protein C Resistance
APCRArmor Piercing Composite Rigid
APCRAssociation pour la Catéchèse en Rural (French: Association for Rural Catechism)
APCRAnalysis, Prompting, Checking, and Reporting
APCRActivate PDP (Packet Data Protocol) Context Request
APCRAssociation Pêche Côtière du Roussillon (French: Coastal Fisheries Association of Roussillon; Roussillon, France)
APCRAnchored Polymerase Chain Reaction (genetics)
APCRAssociation de la Presse Catholique Régionale (French: Regional Catholic Press Association)
APCRAsymmetric Polymerase Chain Reaction (hematology)
References in periodicals archive ?
Certain medium tanks and light tanks use APCR as their default ammo, making them particularly effective at engaging moving targets.
Patients with the aforementioned conditions are frequently screened for the presence of APCR, prothrombin gene mutation, antiphospholipid antibodies, hyperhomocysteinemia, and protein C and S, and antithrombin deficiency; however, SPS is not routinely included in screening for thrombophilia.
El resumen de una muestra selectiva de la literatura que aborda los impactos de los APCU y APCR es presentado en el cuadro 1.
27) Asi, entre 1948 y 1994 se registraron 124 notificaciones a la OMC/GATT para formacion de diversos APCR por sus paises miembros.
La extensa literatura de los modelos teoricos (la cual es descrita en el cuadro 1 de forma selectiva) que analizan los impactos economicos de las APCR puede dividirse en tres grupos.
Los impactos netos sobre el bienestar economico de una economia miembro de un APCR, analizados por el primer grupo de modelos, son descompuestos por Baldwin y Venables (1995) y Lloyd y MacLaren (2004), entre otros, en seis componentes: (30)
El efecto positivo sobre el bienestar de la creacion de comercio, que corresponde al incremento del volumen comercial (exportaciones e importaciones) proveniente del comercio con ambos paises miembros y no miembros de los APCR.
A standard 405 nm light filter permits various coagulation and fibrinolysis tests such as PT, aPIT, TT, FIB, heparm, protein C and S, ATIII, venom time, APCR, and factor assays.
7) A year later, the underlying defect leading to the phenotypic manifestation of APCR was described as a mutation in the coagulation factor V gene.
In this assay system, however, high factor VIII activity, lupus anticoagulant, or factor deficiencies (such as induced by warfarin) can produce an abnormally low APCR ratio in addition to Factor V Leiden.
A year ago, we adopted a policy of performing the APCR assay as a screening step in all samples with an order for Factor V Leiden.
Table 1 Genetic causes of venous thrombosis Common Activated protein C resistance (APCR)/ Factor V Leiden Prothrombin 20210 mutation Methylenetetrahydrofolate reductase gene mutation Increased factor VIII activity Rare Deficiencies of antithrombin and proteins C and S Very Rare Dysfibrinogenemia Table 2 Acquired conditions affecting functional hypercoagulability test results Antithrombin Decreased in heparin use, recent thrombosis, liver disease, DIC, (1) nephrotic syndrome APCR First generation assays: High factor VIII level, LA, (2) acute phase response Second generation assays: Strong LA, (2) pregnancy Factor VIII Elevated in acute phase reaction; falsely decreased in the presence of LA (2) Homocysteine Elevated in recent thrombosis.